Green day on Wednesday for Iterum Therapeutics Plc
(Updated on Dec 08, 2021)
Sell candidate since 2021-11-15 Loss -10.86% PDF
The Iterum Therapeutics Plc stock price gained 1.15% on the last trading day (Wednesday, 8th Dec 2021), rising from $0.49 to $0.49. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 8.24% from a day low at $0.46 to a day high of $0.50. The price has risen in 6 of the last 10 days, but is still down by -1.09% for this period. Volume fell on the last day by -432 thousand shares and in total, 2 million shares were bought and sold for approximately $969.26 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.61% during the next 3 months and, with a 90% probability hold a price between $0.36 and $0.59 at the end of this 3-month period.
Signals & Forecast
There are mixed signals in the stock today. The Iterum Therapeutics Plc stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.53. On a fall, the stock will find some support from the short-term average at $0.47. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 14.33%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss
On the downside, the stock finds support just below today's level from accumulated volume at $0.46 and $0.46. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Iterum Therapeutics Plc finds support just below today's level at $0.46. If this is broken, then the next support from accumulated volume will be at $0.46 and $0.43.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0379 between high and low, or 8.24%. For the last week the stock has had a daily average volatility of 9.76%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Iterum Therapeutics Plc stock A Buy?
Iterum Therapeutics Plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -4.198
Predicted Opening Price for Iterum Therapeutics Plc of Thursday, December 9, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price December 9, 2021||Current price|
Remember To Visit Our YouTube Channel
On Jul 27, 2021 "Gabelli" gave "" rating for ITRM. The price target was changed from $0.63 to 44.2%.
ITRM Insider Trading
|Jul 25, 2021||Buy||80 000||Dunne Michael W.||Ordinary Shares|
|Jun 23, 2021||Buy||36 798||Chin Mark||Restricted Stock Units|
|Jun 23, 2021||Buy||1 936 000||Matthews Judith M.||Stock Option (Right to Buy)|
|Jun 23, 2021||Buy||36 798||Hecht Beth||Restricted Stock Units|
|Jun 23, 2021||Buy||5 280 000||Fishman Corey N.||Stock Option (Right to Buy)|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.